“Anti-COVID-19 drugs rather than SARS-CoV-2 exacerbate myasthenia”, ijmhs, vol. 11, no. 03 (May - June), pp. 1672–1674, May 2021, doi: 10.15520/ijmhs.v11i05.3293.